GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs followed by IHC staining | NA | 0.36 | 1 | 23738757
|
CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | Cisplatin | SFA followed by FACs | NA | 0.36 | 1 | 27035162
|
CXCR4 | 2561 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs followed by IHC staining | NA | 0.36 | 0.0498 | 23738757
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs followed by IHC staining | NA | 0.36 | 0.7582 | 23738757
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by FACs and RT-PCR | NA | 0.36 | 0.7582 | 23715514
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | Western Blotting followed by SFA | NA | 0.36 | 0.7582 | 33721187
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.36 | 0.7582 | 26936993
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.36 | 0.7582 | 32863772
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs | NA | 0.36 | 0.7582 | 28484448
|
ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs for CSC marker followed by SFA and Western Blotting | NA | 0.28 | 0.1739 | 33707423
|
CACNA2D1 | 1399 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs for CSC marker followed by SFA and Western Blotting | NA | 0.28 | 0.0064 | 33707423
|
CDK1 | 1722 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0011 | 33721187
|
MSI1 | 7330 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 23715514
|
NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs for CSC marker followed by SFA and Western Blotting | NA | 0.28 | 0.5461 | 33707423
|
NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.5461 | 33721187
|
NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5461 | 26936993
|
NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5461 | 32863772
|
POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs for CSC marker followed by SFA and Western Blotting | NA | 0.28 | 0.6448 | 33707423
|
POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.6448 | 33721187
|
POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.6448 | 26936993
|
POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.6448 | 32863772
|
SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | FACs for CSC marker followed by SFA and Western Blotting | NA | 0.28 | 0.5695 | 33707423
|
SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.5695 | 33721187
|
SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5695 | 26936993
|
SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5695 | 32863772
|
LIN28A | 15986 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | BME based 3D culture followed by SFA and qRT-PCR | Up | 0.2 | 0.0138 | 34277782
|
MIRLET7C | 31480 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | BME based 3D culture followed by SFA and qRT-PCR | Down | 0.2 | 0.0042 | 34277782
|
MIRLET7F1 | 31483 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | BME based 3D culture followed by SFA and qRT-PCR | Down | 0.2 | 0.0053 | 34277782
|
MIRLET7G | 31485 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | BME based 3D culture followed by SFA and qRT-PCR | Down | 0.2 | 0.0032 | 34277782
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 33721187
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H520 | Cisplatin | SFA followed by FACs | NA | 0.12 | 0.684 | 27035162
|